Elevance Health dividend and valuation

ELV · NYSE · USD

Compare Elevance Health
$433.93Change from previous close: −2.77%Absolute change: −$12.35

Close · November 17, 2026

Valuation

Elevance Health paid $6.87 per share in dividends over the last 12 months (yield 1.6%). Next ex-dividend date: December 4, 2026. The P/E ratio is 18.9. The average price target of 21 analysts is $482.38.

Data as of November 16, 2026

Elevance Health compared with similar companies

Elevance Health's P/E (trailing 12 months): 18.9, in line with the median of a group of 7 similar companies (18.9).

Elevance Health's metrics compared with similar companies
MetricElevance HealthMedian25th–75th percentileBand
P/E (trailing 12 months)18.918.911.9 – 23.2Middle
Forward P/E14.714.39.81 – 16.2Middle
EV/EBITDA9.859.858.65 – 12.3Middle
Price/book2.152.151.69 – 2.42Middle
Price/sales0.480.320.28 – 0.65Middle
Gross margin26.4%13.7%12.5% – 22.5%High
Operating margin4.0%3.9%2.7% – 4.9%Middle
Net margin2.5%2.5%1.6% – 3.1%Middle
ROE11.5%14.4%9.2% – 16.3%Middle
Debt/equity0.690.700.69 – 0.75Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Elevance Health: valuation over time

On the latest fiscal year's earnings (2025), Elevance Health's P/E today is 17.4, in line with the median of its last 10 fiscal years (17.1; between 13.9 and 20.7 from 2016 to 2025). Relative to earnings, it costs about the same as in the past. The dividend yield (1.6%) is above the median of the last 10 fiscal years (1.2%).

Elevance Health P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
2025$350.55$25.2113.9$6.842.0%
2024$368.90$25.6814.4$6.521.8%
2023$471.56$25.2218.7$5.921.3%
2022$512.97$24.8120.7$5.121.0%
2021$463.54$24.7318.7$4.521.0%
2020$321.09$17.9817.9$3.801.2%
2019$302.03$18.4716.4$3.201.1%
2018$262.63$14.1918.5$3.001.1%
2017$225.01$14.3515.7$2.701.2%
2016$143.77$9.2115.6$2.601.8%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$96.04B
Enterprise value
$85.86B
PEG
1.32
EV/revenue
0.43

Profitability and growth

ROA
4.0%
ROIC
6.6%
Revenue growth (year over year)
1.4%
Earnings growth (year over year)
17.9%

Financial health

Total cash
$37.85B
Total debt
$30.76B
Current ratio
1.47
Quick ratio
1.34
Piotroski F-Score
5.00

Dividends

Annual dividend per share
$6.87
Dividend yield
1.6%
Payout ratio
29.2%
Ex-dividend date
December 4, 2026

Analysts and estimates

Average price target
$482.38
Median price target
$492.00
High price target
$523.00
Low price target
$406.00
Analysts with a price target
21
Consensus
Buy
Forward EPS
$30.29
EPS estimate, current year
$29.14

Shares and trading

Beta
0.63
Average volume
1.22M
Shares outstanding
216.06M
Float
215.57M
Institutional ownership
94.8%
Insider ownership
0.3%
Short interest (% of float)
2.4%
Short ratio (days)
3.40